DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2002

DUOPHARMA BIOTECH BHD

Quarterly report for the financial period ended30/09/2002
Quarter3
Financial Year End31/12/2002
The figureshave not been audited

Attachments

DBIOTEC-Q3-20021118(R) (1).xls
87 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2002


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2002 
30/09/2001 
30/09/2002 
30/09/2001 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
15,828
0
47,159
0
2Profit/(loss) before tax
4,871
0
14,468
0
3Profit/(loss)
after tax and minority
interest
3,522
0
5,910
0
4Net profit/(loss) for
the period
3,522
0
5,910
0
5Basic earnings/(loss) per share (sen)
7.13
0.00
24.37
0.00
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

1.5200
0.0000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
Net profit of RM5.910 million for the current year to date under item (4) is arrived at after taking into account pre-acquisition profit of RM4.809 million.

Announcement Info

Company NameDUOPHARMA BIOTECH BHD  
Stock Name DBIOTEC    
Date Announced26 Nov 2002  
CategoryFinancial Results
Reference NoCU-021125-38206

View original report